G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Mounjaro Lawsuit

Mounjaro is Eli Lilly's tirzepatide injection for type 2 diabetes. Plaintiffs allege the same gastrointestinal injuries — gastroparesis, pancreatitis, ileus — that drive the Ozempic litigation occur with Mounjaro as well.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

Mounjaro and tirzepatide injuries

Tirzepatide is a dual GLP-1/GIP receptor agonist. Like semaglutide it dramatically slows gastric emptying and shares a similar adverse-event profile. Eli Lilly is now named alongside Novo Nordisk in MDL 3094.

Do you qualify?

If you took Mounjaro and were diagnosed with a qualifying injury (gastroparesis, severe pancreatitis, intestinal obstruction, gallbladder disease, vision loss, or aspiration), you may have a claim.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.